Latest Articles about CGIX

Cancer Genetics postpones $18 million IPO

Renaissance Capital — Tue, 19 Mar 2013 17:15:02 Z

Cancer Genetics, which offers personalized genomic tests to improve the diagnosis and treatment of cancer, postponed its IPO on Tuesday, citing poor market conditions. The Rutherford, NJ-based

9 US IPOs planned for the week of Mar 18

Renaissance Capital — Mon, 18 Mar 2013 16:00:03 Z

The following IPOs are expected to price this week : Aviv REIT ( AVIV ), a rEIT specializing in post-acute and long-term care skilled nursing facilities, plans to raise $251 million by

US IPO Weekly Recap: Calendar quickly builds, Silver Spring jumps in debut

Renaissance Capital — Sat, 16 Mar 2013 02:16:46 Z

After several companies set terms last week, the US IPO Calendar is packed for the week of March 18. Nine deals are scheduled to price, which would mark the busiest week since the

Diagnostics company Cancer Genetics cuts deal size to $18 million

Renaissance Capital — Mon, 11 Mar 2013 23:38:20 Z

Cancer Genetics, which offers personalized genomic tests to improve the diagnosis and treatment of cancer, announced terms for its IPO on Monday. The Rutherford, NJ-based company plans to raise

Diagnostics company Cancer Genetics again decreases proposed deal size

Renaissance Capital — Mon, 04 Mar 2013 20:45:01 Z

Cancer Genetics, which offers personalized genomic tests to improve the diagnosis and treatment of cancer, lowered the proposed deal size for its upcoming IPO on Monday. The Rutherford,

Weekly Recap: Xoom zips, filing activity picks up for US IPO market

Renaissance Capital — Tue, 19 Feb 2013 18:14:38 Z

Money transfer service Xoom ( XOOM ) surged 59% on Friday, ending 2013's first month and a half of US IPOs on a high note. Xoom's first-day pop is another positive data point, together with

Cancer Genetics postpones second IPO attempt

Renaissance Capital — Fri, 15 Feb 2013 17:44:33 Z

Cancer Genetics, which offers personalized genomic tests to improve the diagnosis and treatment of cancer, postponed its IPO on Friday. The company originally filed for an IPO in January 2012

Cancer Genetics decreases proposed IPO deal size

Renaissance Capital — Thu, 14 Feb 2013 18:11:03 Z

Cancer Genetics, which offers personalized genomic tests to improve the diagnosis and treatment of cancer, lowered the proposed deal size for its upcoming IPO on Thursday. The Rutherford,

5 US IPOs planned for the week of Feb 11

Renaissance Capital — Mon, 11 Feb 2013 17:00:03 Z

The following IPOs are expected to price this week : AutoGenomics ( AGMX ), which provides a molecular diagnostics system for genetic testing in clinical laboratories, plans to raise $60

Cancer Genetics relaunches deal with new underwriters

Renaissance Capital — Tue, 23 Oct 2012 19:27:17 Z

Cancer Genetics, which offers personalized genomic tests to improve the diagnosis and treatment of cancer, lowered the proposed deal size for its upcoming IPO on Tuesday. The Rutherford,

IPO activity remains slow despite Facebook offering

Renaissance Capital — Sat, 19 May 2012 02:01:29 Z

Much of the air in the IPO market was filled with Facebook, as it headlined what was a slow week in IPO activity. Only two other companies were on the calendar and neither was

Cancer Genetics postpones $48 million US IPO

Renaissance Capital — Fri, 18 May 2012 02:10:18 Z

Cancer Genetics, which offers personalized genomic tests to improve the diagnosis and treatment of cancer, postponed its IPO on Thursday. The Rutherford, NJ-based company was founded

3 US IPOs planned for the week of May 14

Renaissance Capital — Mon, 14 May 2012 16:00:05 Z

The following IPOs are expected to price this week : Cancer Genetics ( CGIX ), which offers personalized genomic tests to improve the diagnosis and

Diagnostics company Cancer Genetics sets terms for $48 million US IPO

Renaissance Capital — Mon, 07 May 2012 19:00:10 Z

Cancer Genetics, which offers proprietary genomic tests to improve the diagnosis, prognosis and treatment of cancer, announced terms for its IPO on Monday. The Rutherford, NJ-based